Oct
2022

EYRIS RECEIVES REGULATORY APPROVAL FROM THAI FOOD & DRUG ADMINISTRATION (FDA)

11 Oct 2022 – EyRIS is excited to announce that SELENA+, our artificial intelligence deep learning system has received regulatory approval from the Thai Food and Drug Administration (FDA). We cannot wait for the deployment of our product in Thailand and stand ready to join their fight against diabetes. Diabetes is an exploding epidemic throughout the world. Thailand has certainly…

Read more

Sep
2022

EYRIS: A HEALTHCARE INNOVATION SHAPING A HEALTHIER FUTURE

Sep 2022 – On its annual global brand campaign, the Economic Development Board, Singapore demonstrates Singapore’s spirit of innovating against the odds together with businesses, through a shared belief to do better together. This year, one of EBD’s Pillars of Purpose is “Creating a Healthier World”. EyRIS was spotlighted as one of the Singaporean companies’ quest to develop solutions to…

Read more

Sep
2022

DEXIE SHOWCASED IN COMMUNITY CARE ORGANISATION

Sep 2022 – Singapore, like many developed countries, faces the challenge of an aging society and developing the care infrastructure to cope and accommodate the rising number of elders who require long term care. As such the Singapore government is introducing initiatives through Agency for Integrated Care (AIC) such as the Community Care Digital Transformation Plan (CCDTP) to encourage Community…

Read more

Aug
2022

NIU’EIKI HOSPITAL GOES LIVE ON VESALIUS

12 Aug 2022 – Our congratulations to Ministry of Health, Tonga for the successful deployment of VESALIUS Hospital Information & Electronic Medical Record Systems in Niu’eiki Hospital on ‘Eua Island. This roll-out is part of a Nationwide Health Information System (HIS) and Electronic Medical Record (EMR) project for the Kingdom of Tonga funded by Asian Development Bank. The project spans…

Read more

Aug
2022

EYRIS CO-FOUNDER RECEIVES ARVO ACHIEVEMENT AWARD

10 Aug 2022 – Our heartiest congratulations to our co-founder of EyRIS Prof Wong Tien Yin for being awarded the ARVO Achievement Award – Friedenwald Award 2023 by the Association for Research in Vision and Ophthalmology (ARVO). This award honours clinical research in ophthalmology and pays tribute to Dr Jonas S. Friedenwald, who made numerous contributions to the field. Distinguished…

Read more

Jul
2022

EYRIS FEATURED ON MEDIACORP CHANNEL 8 TO SHOWCASE THE CHRONIC KIDNEY DISEASE DETECTION ALGORITHM

14 Jul 2022 – EyRIS recently had the opportunity to showcase her latest innovation, RetiKid, on Mediacorp Channel 8 Primetime News segment. RetiKid is a deep learning algorithm that is able to detect Stage 3 and above chronic kidney disease (CKD) using retinal fundus images, without the need to draw any blood from the patient. RetiKid can be marketed in…

Read more

Jun
2022

CVSKL MOBILE APP OFFICIAL LAUNCH

16 Jun 2022 – Cardiac Vascular Sentral Kuala Lumpur (CVSKL), an integrated cardiac and vascular hospital in Kuala Lumpur recently launched CVSKLgo, a healthcare mobile app solution developed by Nova to strengthen patient engagement. As part of CVSKL’s digital transformation initiatives, Nova the provider of VESALIUS Hospital Information System (HIS) to CVSKL has customized VESALIUS.m mobile app to meet hospital’s…

Read more

Jun
2022

DEXIE MAKES DEBUT AT COMMUNITY CARE SEMINAR

13 Jun 2022 – Dexie, Dex-Lab’s first Social Robot, was showcased at the Agency for Integrated Care’s (AIC) Annual Community Care Work Plan Seminar, which was graced by Singapore Health Minister Ong Ye Kung. Dexie is made possible by the team that worked tirelessly for 2 years that oversaw the Research and Development of the world’s first, one of its…

Read more

May
2022

DEXIE RECEIVES RECOGNITION IN WORLD AGEING FESTIVAL 2022

May 2022 – DEX-Lab is thrilled to announce that DEXIE, our multi-competency social robot developed to assist care staff in nursing homes to engage with people with dementia, was named finalist for two categories in Ageing Asia’s World Ageing Festival 2022; namely Innovation of the year – Dementia Care Program & Technology. Our partner, Goshen Consultancy, are leaders in the…

Read more

Mar
2022

NOVA COLLABORATES WITH NUS IN R&D TO DEVELOP STRUCTURAL BIM AUTOMATED COMPLIANCE SYSTEM

Mar 2022 – Nova is delighted to announce National University of Singapore (NUS) has awarded a contract us to do research collaboration to develop a solution to link and check Structural Analysis & Design (A&D) reports against Building Information Modelling (BIM) models.     In the current workflow, typically there is a discontinuity in term of the Structural BIM and…

Read more

Feb
2022

NOVA COLLABORATES WITH AMO & RHAZES TO BRING SELENA+ TO MAINSTREAM ADOPTION

17 Feb 2022 – NOVA MSC Berhad, the exclusive distributor of EyRIS’ products in Malaysia, has signed a Memorandum of Understanding with the Association of Malaysian Optometrists (AMO) and Rhazes Consultancy Services Sdn Bhd (RHAZES), a tele-pharmacy platform provider, to bring its AI Deep Learning Technology, SELENA+ to mainstream adoption in Malaysia. Under the collaboration, EyRIS’ AI deep learning technology,…

Read more

Feb
2022

EYRIS PARTNERS WITH CENTRE FOR MEDICAL TECHNOLOGIES & INNOVATIONS TO DEVELOP AI TO DETECT MELANOMA

14 Feb 2022 – Riding on the success of SELENA+, EyRIS has sought to expand our capabilities by investing in cutting edge AI deep learning technology to detect other form of diseases. Through the National Healthcare Group (NHG) Centre for Medical Technologies & Innovations (CMTi), EyRIS is thrilled to announce a new Research Collaboration Agreement with a Public Healthcare Institute…

Read more